Sanara MedTech appoints former LHC Group CEO Keith Myers to board; James Stuckert resigns as director

Sanara MedTech Inc.

James W. Stuckert resigned as director effective Oct 4, 2024; will remain as Director Emeritus in non-voting advisory capacity.
Keith Myers appointed to board; he co-founded LHC Group and served as chairman/CEO until LHC's merger with Optum in 2023.
Myers will serve on Corporate Development Committee; receives $90k annual board retainer and $5k committee fee under standard policy.
Stuckert's resignation was not due to any disagreement with the company's operations, policies, or practices.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James W. Stuckert

Director

SMTI · Sanara MedTech Inc.

Effective: 2024-10-04
Successor: Keith Myers
Filed: October 7, 2024, 7:59 PM ET

On October 4, 2024, James W. Stuckert notified Sanara MedTech Inc. (the “Company”) of his intention to resign from his position as a member of the Company’s Board of Directors (the “Board”) and each of its committees upon which he serves, effective as of October 4, 2024.

Appointed

Keith Myers

Director

SMTI · Sanara MedTech Inc.

Effective: 2024-10-04
Filed: October 7, 2024, 7:59 PM ET

On October 4, 2024, the Board appointed Keith Myers as a director of the Company, effective October 4, 2024 (the “Effective Date”), to fill the vacancy resulting from Mr. Stuckert’s resignation.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James W. Stuckert resigned as Director at Sanara MedTech Inc..

Action: resigned
Role: Director

Exact text from the filing

On October 4, 2024, James W. Stuckert notified Sanara MedTech Inc. (the “Company”) of his intention to resign from his position as a member of the Company’s Board of Directors (the “Board”) and each of its committees upon which he serves, effective as of October 4, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Keith Myers was appointed as Director at Sanara MedTech Inc..

Action: appointed
Role: Director

Exact text from the filing

On October 4, 2024, the Board appointed Keith Myers as a director of the Company, effective October 4, 2024 (the “Effective Date”), to fill the vacancy resulting from Mr. Stuckert’s resignation.

View on SEC.gov

Sanara MedTech Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-040275

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.